Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study.

Kivitz, Alan J   •   Wagner, Ulf   •   Dokoupilova, Eva   •   Supronik, Jerzy   •   Martin, Ruvie   •   Talloczy, Zsolt   •   Richards, Hanno B   •   Porter, Brian

published in: Rheumatology and therapy